Cripto in tumors and embryo development.

[1]  G. Viglietto,et al.  A Truncated Form of Teratocarcinoma-Derived Growth Factor-1 (Cripto-1) mRNA Expressed in Human Colon Carcinoma Cell Lines and Tumors , 2001, Tumor Biology.

[2]  A. Brivanlou,et al.  The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. , 2001, Genes & development.

[3]  M. Whitman,et al.  Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. , 2001, Molecular cell.

[4]  A. Ebert,et al.  Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells. , 2001, Experimental cell research.

[5]  K. Williams,et al.  The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. , 2000, Endocrine-related cancer.

[6]  G. Schoenwolf,et al.  Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis. , 2000, Gene.

[7]  A. Schier,et al.  The EGF-CFC gene family in vertebrate development. , 2000, Trends in genetics : TIG.

[8]  W. Yasui,et al.  Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas. , 2000, European journal of cancer.

[9]  E. Adamson,et al.  Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development , 2000, Mechanisms of Development.

[10]  M. Rocchi,et al.  Assignment of human teratocarcinoma derived growth factor (TDGF) sequences to chromosomes 2q37, 3q22, 6p25 and 19q13.1 , 1999, Cytogenetic and Genome Research.

[11]  W. Talbot,et al.  The EGF-CFC Protein One-Eyed Pinhead Is Essential for Nodal Signaling , 1999, Cell.

[12]  A. Ebert,et al.  Cripto-1 Indirectly Stimulates the Tyrosine Phosphorylation oferb B-4 through a Novel Receptor* , 1999, The Journal of Biological Chemistry.

[13]  E. Adamson,et al.  Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. , 1999, Development.

[14]  C. Bianco,et al.  Cripto: a novel epidermal growth factor (EGF)‐related peptide in mammary gland development and neoplasia , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  A. Wynshaw-Boris,et al.  Cripto is required for correct orientation of the anterior–posterior axis in the mouse embryo , 1998, Nature.

[16]  F. Hamdy,et al.  The immunohistochemical detection of cripto‐1 in benign and malignant human bladder , 1998, The Journal of pathology.

[17]  E. Adamson,et al.  Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. , 1998, Developmental biology.

[18]  Alexander F. Schier,et al.  Positional Cloning Identifies Zebrafish one-eyed pinhead as a Permissive EGF-Related Ligand Required during Gastrulation , 1998, Cell.

[19]  C. Bianco,et al.  Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  Stefania Staibano,et al.  Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1 , 1997, Oncogene.

[21]  E. Dmitrovsky,et al.  Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  M. Sternberg,et al.  Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto. , 1997, Biochemistry.

[23]  N. Normanno,et al.  Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[24]  P. Leder,et al.  A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation. , 1997, Development.

[25]  H. Sasano,et al.  Expression of Epidermal Growth Factor‐Related Proteins and Epidermal Growth Factor Receptor in Common Epithelial Ovarian Tumors , 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[26]  H. Kuniyasu,et al.  EXPRESSION OF CRIPTO IN HUMAN GALL BLADDER LESIONS , 1996, The Journal of pathology.

[27]  E. Dmitrovsky,et al.  Transfection with a CRIPTO anti‐sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line , 1996, International journal of cancer.

[28]  M. Merino,et al.  Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues , 1996, International journal of cancer.

[29]  D. Salomon,et al.  Detection of amphiregulin and Cripto‐1 in mammary tumors from transgenic mice , 1996, Molecular carcinogenesis.

[30]  S. Takashima,et al.  Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas. , 1995, Japanese journal of clinical oncology.

[31]  M. Kirschner,et al.  The identification of two novel ligands of the fgf receptor by a yeast screening method and their activity in xenopus development , 1995, Cell.

[32]  S. Tatebe,et al.  Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study. , 1995, Anticancer research.

[33]  W. Yasui,et al.  Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. , 1995, British Journal of Cancer.

[34]  A. Prats,et al.  Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes , 1995, Molecular and cellular biology.

[35]  Susan E. Johnson,et al.  Expression of epidermal growth factor family gene members in early mouse development , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[36]  D. O'connor,et al.  Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis. , 1994, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[37]  N. Normanno,et al.  Identification and biological characterization of an epidermal growth factor-related protein: cripto-1. , 1994, The Journal of biological chemistry.

[38]  G. Merlo,et al.  Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. , 1994, British Journal of Cancer.

[39]  H. Friess,et al.  Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitis , 1994, International journal of cancer.

[40]  W. Yasui,et al.  Expression of cripto in Human Pancreatic Tumors , 1994, Japanese journal of cancer research : Gann.

[41]  A. Simeone,et al.  The murine cripto gene: expression during mesoderm induction and early heart morphogenesis. , 1993, Development.

[42]  N. Normanno,et al.  Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. , 1992, Cancer research.

[43]  Kazuhiro Yoshida,et al.  Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas , 1991, Japanese journal of cancer research : Gann.

[44]  A. Ciccodicola,et al.  Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. , 1991, American journal of human genetics.

[45]  D. Salomon,et al.  Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. , 1991, Cancer research.

[46]  Silvana,et al.  Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells. , 1989, The EMBO journal.

[47]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[48]  C. Angeletti,et al.  Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  W. Yasui,et al.  Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions. , 1998, European Journal of Gynaecological Oncology.

[50]  M. Desantis,et al.  Purification and characterization of a recombinant human cripto-1 protein. , 1998, Growth factors.